Skip to main content
Vaccines logoLink to Vaccines
. 2022 Jun 30;10(7):1052. doi: 10.3390/vaccines10071052

Correlates of Zero-Dose Vaccination Status among Children Aged 12–59 Months in Sub-Saharan Africa: A Multilevel Analysis of Individual and Contextual Factors

Chamberline E Ozigbu 1, Bankole Olatosi 1,2,3, Zhenlong Li 2,3,4, James W Hardin 1,5, Nicole L Hair 1,*
Editor: Amine A Kamen
PMCID: PMC9322920  PMID: 35891216

Abstract

Despite ongoing efforts to improve childhood vaccination coverage, including in hard-to-reach and hard-to-vaccinate communities, many children in sub-Saharan Africa (SSA) remain unvaccinated. Considering recent goals set by the Immunization Agenda 2030 (IA2030), including reducing the number of zero-dose children by half, research that goes beyond coverage to identify populations and groups at greater risk of being unvaccinated is urgently needed. This is a pooled cross-sectional study of individual- and country-level data obtained from Demographic and Health Surveys Program and two open data repositories. The sample includes 43,131 children aged 12–59 months sampled between 2010 and 2020 in 33 SSA countries. Associations of zero-dose status with individual and contextual factors were assessed using multilevel logistic regression. 16.5% of children had not received any vaccines. Individual level factors associated lower odds of zero-dose status included mother’s primary school or high school education, employment, use of antenatal care services and household wealth. Compared to children in countries with lower GDP, children in countries with relatively high GDP had nearly four times greater odds of being unvaccinated. Both individual and contextual factors are correlated with zero-dose status in SSA. Our results can inform efforts to identify and reach children who have not received any vaccines.

Keywords: infectious diseases, vaccination, immunization, zero-dose, children, sub-Saharan Africa

1. Introduction

Vaccine discovery and mass distribution through the Expanded Program on Immunization (EPI) established in 1974, remains one of the greatest public health achievements in reducing morbidity and mortality among children globally [1,2,3]. Since EPI debut, many under-five children in low-and-middle income countries (LMICs) have been saved from catastrophic diseases such as Polio, Measles, Diphtheria, Tetanus, Pertussis and Tuberculosis [4,5,6,7,8]. The use of vaccines prevents over 2.5 million deaths each year in under-five children [9,10]. Despite this progress, 1 in 5 children in SSA lack access to necessary life-saving vaccines [11]. As a result, more than 30 million African children under age 5 are affected by vaccine-preventable diseases and, of those, more than 500,000 die each year [12].

Because of these benefits, governments, and international organizations have developed innovative strategies to improve vaccination coverage and penetration into hard-to-reach areas. These strategies include, Reaching Every District (RED) approach, Global Immunization Vision and Strategy (GIVS), and the Global Vaccine Action Plan (GVAP) [13,14,15]. Apart from these strategies, over USD 112 billion funding was provided for vaccine coverage between 2000 and 2017 [16]. However, the focus on “coverage” misses a potentially important population: children with zero-dose vaccination status.

World Health Organization (WHO) and United Nations Children’s Fund (UNICEF) estimates show that 14 million and 17 million zero-dose children exist between 2019 and 2020, respectively, and they mainly reside in 10 lower middle-income countries (LMICs) [17,18,19]. This report indicates that the number of children who should have received the required immunization during the eligibility period (i.e., before their first birthday) and the formative years that follow, is growing [17,18,19]. Inability to reach the zero-dose children could be a pointer to why achieving the 90% goal of vaccine coverage at country and regional level remains a hurdle in SSA to date [20].

To ensure that no child is left behind, the World Health Assembly set an ambitious target of reducing the number of zero-dose children by 50% through the Immunization Agenda 2030 (IA2030) [21]. This is also embodied in the Sustainable Development Goals (SDGs) target 3.2, aimed at ending preventable deaths of newborns and under-five children by 2030 [22]. Achieving the goals outlined in both IA2030 and SDGs requires sufficient research and attention particularly directed to the zero-dose children.

Children with zero-dose vaccination status are at increased risk for infections with vaccine preventable diseases (VPDs) such as measles, polio, and pneumonia, during the first 5 years of life [23]. They are also part of the world’s most vulnerable population, more likely to suffer from disability and mortality that could easily be prevented through immunization [24,25,26]. These children are predominantly less privileged, live in rural households, and raised by mothers with little or no education, indicating disparity within countries [27,28,29]. Lack of attention to the zero-dose population may pose a public health threat in the future, leading to re-emergence of eradicated diseases such as polio, and/or potential disease outbreak such as measles.

While many studies have enumerated factors that impact vaccination coverage, uptake, timeliness, and drop-out rates among specific or different immunization in SSA; how these factors affect the zero-dose population have not been comprehensively examined since most studies are country, facility or intervention-specific, limiting their generalizability [4,5,7,8,9]. For example, while a recent study examined correlates of never-vaccinated children in Nigeria, [23] it is not clear how the results could be generalized in other African countries given the vastly different context across countries in SSA. Similarly, a multi-country study shows that unvaccinated children remain undetected and/or underreported by routine monitoring [30]. This study broadly reported on LMICs without accounting for nuances in Africa. A comprehensive multinational study with primary focus in SSA is needed to fill these gaps. Arambepola et al., reported that incomplete knowledge on factors influencing zero-dose children in SSA needs to be properly investigated [25]. Given the growing concern of changing the status of children from zero-dose to fully vaccinated is yet to be addressed, more studies are needed to identify factors affecting zero-dose children [24,31].

The objective of this study is to identify populations and groups of children at greater risk of being unvaccinated (zero-dose). Considering the high under-five mortality rate in SSA and reports that immunization coverage has plateaued in recent years, we hypothesized that the prevalence of children with zero-dose vaccination status would be high. We also hypothesized that both individual and contextual factors play a role in whether or not a child has been vaccinated. In testing this hypothesis, this study aims to define the prevalence of children with zero-dose vaccination status and examine the independent associations of individual and contextual factors with zero-dose vaccination status among children aged 12–59 months in SSA. Our results can inform efforts to identify and reach children who have not received any vaccines.

2. Materials and Methods

2.1. Data Sources

We obtained individual and household-level data from the Demographic and Health Survey (DHS) program [32]. The DHS program started over 35 years ago, with over 400 surveys conducted in over 90 countries since inception [33,34]. The DHS data are nationally representative, cross-sectional, household surveys typically conducted every 5 years to track progress related to national development targets at various levels [34]. The DHS surveys are conducted using standard approach designed to allow for comparison between countries or regions [33]. Detailed information is collected on diverse areas including childhood immunization, infant and child mortality, maternal and child health, reproductive health, Malaria, HIV/AIDS and family planning among others [35]. The DHS program uses a stratified two-stage cluster probabilistic sampling design, with response rates typically exceeding 90% [36]. The first stage involves selection of the primary sampling units (PSUs) called the Enumeration Areas (EA) drawn from census files with the probability of selecting a unit proportional to its size within each stratum [33]. In the second stage, a sample of household is drawn from an updated list of households by equal probability systematic sampling in each EA selected [33]. Details about the DHS program and sampling design has been published elsewhere [35]. We selected countries in SSA with a standard DHS conducted between 2010–2020 for the study (i.e., survey conducted within the last 10 years). This yielded a total of 33 eligible countries (Table 1).

Table 1.

Summary of eligible SSA countries and the DHS survey features.

Country Survey Year Sample Size (Weighted)
Angola 2015–2016 1458
Burkina Faso 2010 1618
Benin 2017–2018 1403
Burundi 2016–2017 622
Congo DRC 2013–2014 5336
Congo 2011–2012 1882
Cote d’Ivore 2011–2012 767
Cameroun 2018 482
Ethiopia 2016 2407
Gabon 2012 726
Ghana 2014 396
Gambia 2019–2020 101
Guinea 2018 471
Kenya 2014 2219
Comoros 2012 866
Liberia 2019–2020 345
Lesotho 2014 210
Mali 2018 1769
Malawi 2015–2016 515
Mozambique 2011 1703
Nigeria 2018 2670
Niger 2012 2338
Namibia 2013 375
Rwanda 2014–2015 250
Sierra Leone 2019 416
Senegal 2010–2011 1557
Chad 2014–2015 6712
Togo 2013–2014 1013
Tanzania 2015–2016 635
Uganda 2016 557
South Africa 2016 128
Zambia 2018 853
Zimbabwe 2015 331
Total 43,131

We also obtained country-level data from reports published by the World bank: GDP per capita, literacy rate, fertility rate, health expenditure, unemployment rate, physician density, [37] and the Institute for Economics and Peace (IEP): Global Peace Index (GPI), [38] using each country’s most recent available data consistent or closely related to the DHS survey year.

2.2. Study Design and Sample Size

This study was a secondary data analysis of existing data on childhood immunization and utilized a pooled cross-sectional study design. Approximately 44,800 children whose mothers are within the reproductive age group (15–49 years) were initially sampled. Our analysis sample includes 43,131 children whose mother had no missing information on vaccination status and important demographic characteristics.

2.3. Measures

2.3.1. Outcome Variable

Our outcome variable was an indicator for a child’s zero-dose vaccination status. We created a binary variable that was equal to 1 if a child had not yet received any childhood vaccine indicated for children between the ages of 12–59 months. To assess this outcome, the interviewer asked mothers two questions. First, “can they present child immunization card that contain the vaccination history?” This initial step was taken to minimize recall bias. Mothers who could not present an immunization card were asked the child specific follow-up question–“ever had any vaccination?”.

Children of mothers who could present child immunization card (reflected in the card to have participated in no episode of vaccination) and of mothers who were not in possession of immunization card and who responded “no” to the child specific follow-up question were categorized ‘zero-dose’ and were coded “1”. Mothers who could present child immunization card (reflected in the card to have participated in at least one episode of vaccination) and responded “yes” to the follow-up question were categorized “vaccinated” and were coded “0”.

2.3.2. Explanatory Variables

The selection of explanatory variables was guided by the literature and data availability and were grouped into two categories: individual factors and contextual factors. Contextual factors were further divided into those collected in the DHS surveys and measured at the household level and those collected from other publicly available data sources and measured at the national level.

Individual Factors

Individual factors included child’s sex (male [ref group] or female), child’s age measured in months (12–24 [ref group], 24–36, 37–48, or 49–59),birth order (1 [ref group], 2–3, 4–5, or 6+), birth weight (low, normal, high, or not weighed [ref group]),mother’s age measured in years (15–19 [ref group], 20–24, 25–34, 35–39, 40–44, or 45–49), mother’s marital status (single/widowed [ref group] or married/cohabitating), mother’s education (no education [ref group], primary school, incomplete high school, or completed high school), mother’s occupation (unemployed [ref group] or employed), antenatal care utilization (no visit [ref group], <4 visits, ≥4 visits, or not asked), place of delivery (home [ref group], public hospital, private hospital, or other location), and exposure to mass media (no TV/radio [ref group] or TV/radio).

Contextual Factors

Contextual factors collected in the DHS surveys and measured at the household level included place of residence (urban [ref group] or rural), household wealth index quintile (poorest [ref group], poorer, middle, richer, or richest), and religion (Christian [ref group], Muslim, other religion, no religion, or not asked). Contextual factors measured at the national level included GDP per capita, domestic general government health expenditure (as a percentage of general government expenditure), adult female literacy rate, female unemployment rate, fertility rate, physicians per 1000 people, and Global Peace Index (GPI) overall score. The GPI is a composite index measuring the peacefulness of countries. It is made up of 23 quantitative and qualitative indicators each weighted on a scale of 1–5. The lower the score the more peaceful the country [38]. For government health expenditures, literacy rate, unemployment rate, and fertility rate, we categorized countries into two groups (low [ref group] or high) relative to the median value to provide results that were more easily interpretable. For GDP per capita, physician density, and the GPI, we assigned countries to tertiles (low [ref group], moderate, high) to allow for nonlinear effects. We also included indicators for subregions of Africa defined by the United Nations (Western Africa [ref group], Eastern Africa, Middle Africa, or Southern Africa).

2.3.3. Control Variable

Given the differential timing of DHS surveys across sample countries, we included birth year as a partial control for common trends over the sample period and to adjust for effects of unobserved temporal factors.

2.4. Data Analysis

We applied the method suggested by the DHS to de-normalize the weights for each of the countries, [39] using the United Nations population of women between the ages of 15–49 years (i.e., women of reproductive age) corresponding to the year of survey [40]. Weighted descriptive statistics were performed to summarize the data. We examined the association between zero-dose vaccination status and all explanatory variables. Statistical differences across groups were examined using chi-squared test.

A 2-level multilevel logistic regression analysis was performed to account for the hierarchical nature of the data: individual observations (level one) were nested within countries (level two). Five mixed effect models were fitted as follows: Model 0 (null model, no variables); Model 1: (individual factors); Model 2 (contextual factors measured at the household level); Model 3 (contextual factors measured at the national level), and Model 4 (full model, all individual and contextual factors). Model 1–Model 4 also included birth year as a control variable. We evaluated variance inflation factors (VIFs) to assess multicollinearity among the explanatory variables. A value exceeding 10 was used as the cut-off point [41]. No multicollinearity among the explanatory variables were observed (mean VIF = 1.41, range = 1.0–2.54). We reported both fixed effects (measures of association) and random effects (measures of variation). Fixed effects were summarized using adjusted odds ratios (aORs), with associated 95% confidence intervals (CIs), whereas random effects were assessed by the Intra-class correlation (ICC), median odds ratio (MOR), and proportional change in variance (PCV) [42,43,44,45,46]. We used the Bayesian Information Criterion (BIC) and Akaike Information Criterion (AIC) to assess goodness-of-fit of models. The model with the lowest value was considered the best explanatory model. For variables with 2.5% missingness (religion and antenatal care), the missing values were recoded and included as a separate category in the analysis. In alternative specifications, we removed religion and antenatal care from the full model, respectively. However, our results were not sensitive to these modifications and were qualitatively comparable. We further removed both variables concurrently in the full model, and our results remained unchanged. To ensure representativeness of the sample, the sampling weights were applied to the models. A p-value less than 0.05 was deemed statistically significant. All statistical analyses were performed using Stata Statistical Software, version 15.1, College Station, TX, USA StataCorp LLC.

3. Results

3.1. Descriptive Statistics and Bivariate Analysis

Table 2 and Table 3 present baseline characteristics and bivariate analyses of individual and contextual factors, respectively, in a weighted sample of 43,131 children aged 12–59 months in SSA. 16.5% of children were zero-dose, i.e., had not received any vaccines.

Table 2.

Baseline characteristics and bivariate analysis of individual factors associated with zero-dose vaccination status among children aged 12–59 months in SSA (N = 43,131).

Characteristics Univariate Bivariate
n % Zero-Dose Vaccinated p-Value
n % n %
    Vaccinated 35,920 83.5
    Zero-dose 7211 16.5
Child’s sex
    Male 21,684 50.7 3601 16.4 18,083 83.6 0.6898
    Female 21,447 49.3 3610 16.7 17,837 83.3
Child’s age (months)
    12–24 12,884 35.7 2542 20.1 10,342 79.9 <0.0001
    25–36 14,836 38.7 2613 17.8 12,223 82.2
    37–48 8034 13.3 1048 9.8 6986 90.2
    49–59 7377 12.4 1008 9.4 6369 90.6
Birth order
    1 7930 18 1177 15.0 6753 85.0 0.0316
    2–3 14,262 32.7 2343 15.9 11,919 84.1
    4–5 10,470 24 1880 16.7 8590 83.3
    6+ 10,469 25.4 1811 18.2 8658 81.8
Birth weight
    Low BW 1733 3.7 140 9.1 1593 91 <0.0001
    Normal BW 12,389 26.4 713 5.3 11,676 94.7
    High BW 3,427 8.4 202 6.0 3225 94.0
    Not weighed 25,582 60.5 6156 23.5 19,426 76.5
Mother’s age (years)
    15–19 2167 4.4 449 21.8 1718 78.2 0.0135
    20–24 9254 21 1546 17.7 7708 82.3
    25–34 21,048 50.5 3469 15.6 17,579 84.4
    35–39 6545 14.9 1047 16.1 5498 83.9
    40–44 3073 7.0 502 16.6 2571 83.4
    45–49 1044 2.2 198 17.4 846 82.6
Mother’s marital status
    Single/Widowed 4722 9.9 586 12.8 4136 87.2 0.0005
    Married/Co-habiting 38,409 90.1 6625 16.9 31,784 83.1
Mother’s educational level
    No education 22,115 47.6 5280 23.7 16,835 76.3 <0.0001
    Primary school 12,468 30.8 1351 12.4 11,117 87.6
    Incomplete high school 6204 13.6 450 7.0 5754 93.0
    Completed high school 2344 8.0 130 5.49 2214 94.5
Mother’s occupation
    Unemployed 18,580 43.3 3982 21.1 14,598 78.9 <0.0001
    Employed 24,551 56.7 3229 13.0 21,322 87.0
Antenatal visit
    No visit 6703 18.1 2750 35.9 3953 64.1 <0.0001
    <4 visits 8206 20.1 913 13.3 7293 86.7
    4 or more visits 11,972 28.8 887 8.97 11,085 91.0
    Not asked 1 16,250 33 2661 14.5 13,589 85.5
Place of child’s delivery
    Home 20,522 48.6 5399 24.6 15,123 75.4 <0.0001
    Public hospital 18,980 40.3 1323 7.76 17,657 92.2
    Private hospital 2431 7.7 161 6.34 2270 93.7
    Other 1198 3.4 328 28.0 870 72.0
Exposure to Media
    No TV/Radio 20,497 50.7 4188 20.2 16,309 79.8 <0.0001
    Has TV/Radio 22,634 49.3 3023 12.7 19,611 87.3

1 Question not asked in DHS Survey. Questions regarding the number of antenatal care visits were asked in reference to a woman’s most recent pregnancy (youngest child) only.

Table 3.

Baseline characteristics and bivariate analysis of contextual factors associated with zero-dose vaccination status among children aged 12–59 months in SSA (N = 43,131).

Characteristics Univariate Bivariate
n % Zero-Dose Vaccinated p-Value
n % n %
    Vaccinated 35,920 83.5
    Zero-dose 7211 16.5
Place of residence
    Urban 11,223 25.0 1223 8.67 10,000 91.3 <0.0001
    Rural 31,908 75.0 5988 19.1 25,920 80.9
Wealth index
    Poorest 12,902 26.3 2778 23.5 10,124 76.5 <0.0001
    Poorer 9430 23.1 1726 20.3 7704 79.7
    Middle 8039 20.0 1270 14.8 6769 85.2
    Richer 7185 17.4 976 10.4 6209 89.6
    Richest 5575 13.2 461 6.59 5114 93.4
Religion
    Christian 20,339 55.4 2329 12.3 18,010 87.7 <0.0001
    Islam 16,181 31.6 3966 25.2 12,215 74.8
    Others 2231 2.8 264 15.0 1967 85.0
    No religion 1222 1.9 240 18.7 982 81.3
    Not asked 1 3158 8.3 412 11.1 2746 88.9
GDP per capita 2
    Low 16,540 54.7 2120 15.2 14,420 84.8 <0.0001
    Moderate 14,867 20.2 3060 15.3 11,807 84.7
    High 11,724 25.1 2031 20.4 9693 79.6
Health expenditure 2
    Low 28,317 76.2 5361 17.6 22,956 82.4 <0.0001
    High 14,814 23.8 1850 13.1 12,964 86.9
Literacy rate 2
    Low 26,057 61.3 5740 21.9 20,317 78.1 <0.0001
    High 17,074 38.7 1471 7.94 15,603 92.1
Unemployment rate 2
    Low 27,596 70.8 4753 15.6 22,843 84.4 0.0002
    High 15,535 29.2 2458 18.8 13,077 81.2
Fertility rate 2
    Low 17,776 40.2 2492 18.6 15,284 81.4 0.0001
    High 25,355 59.8 4719 15.1 20,636 84.9
Physician density 2
    Low 19,315 41.6 3785 20.4 15,530 79.6 <0.0001
    Moderate 12,323 31.2 1449 9.51 10,874 90.5
    High 11,493 27.2 1977 18.6 9516 81.4
Global Peace Index 3
    Low 10,765 15.8 1308 13.1 9457 86.9 <0.0001
    Moderate 15,777 39.6 2905 21.1 12,872 78.9
    High 16,589 44.5 2998 13.6 13,591 86.4
UN African Sub-region
    Western Africa 14,864 31.1 2484 18.2 12,380 81.8 <0.0001
    Eastern Africa 10,958 35.4 1691 20 9267 80.0
    Middle Africa 16,596 32.2 2997 11.4 13,599 88.6
    Southern Africa 713 1.4 39 8.6 674 91.4

1 Question not asked in DHS Survey. Data unavailable for South Africa, Tanzania, and Niger. 2 National measures of GDP per capita, domestic general government health expenditure as a percentage of general government expenditure, adult female literacy rate, female unemployment rate, fertility rate, physicians per 1000 people were obtained from the World Bank [37]. 3 National measures of the Global Peace Index (GPI) overall score were obtained from the Institute for Economics and Peace (IEP). The GPI is a composite index measuring the peacefulness of countries. The lower the score the more peaceful the country [38].

3.1.1. Individual Factors

Among children, roughly one-half were male (50.7%) and one-quarter were older than 36 months (13.2% aged 37–48 months and 12.4% aged 49–59 months). Among mothers, roughly one-quarter were under age 25 (4.4% aged 15–19 years and 21% aged 20–24 years), one-half were between the ages of 25 and 34 (50.5%), and one-quarter were over age 35 (14.9% aged 35–39 years, 7.0% 40–44 years, and 2.2% 45–49 years). Nearly all mothers were married or cohabitating (90.1%), and the vast majority reported no secondary level education (47.6% no formal schooling and 30.8% primary school only). More than 50% of mothers were employed (56.7%). Nearly one-half of children were born at home (48.6%). The second most common place of birth was public hospital (40.3%). More than 60% of mothers reported that their child had not been weighed at birth (60.5%). Compared to children whose birth weight was recorded, children who were not weighed were significantly more likely to be zero-dose (25% versus 9.1%, 5.3%, and 6.0% for low, normal and high birth weight, respectively). While risk of zero-dose status diminished with age, nearly one-tenth of children older than 36 months remained unvaccinated (9.8% and 9.4% of children aged 37–48 months and 49–59 months, respectively). By comparison, 20.1% of children aged 12–24 months and 17.8% of children aged 15–36 months were unvaccinated. Children born to mothers who had no formal education (23.7% versus 12.4% and 5.49% for completed primary and secondary education, respectively), who were unemployed (21.1% versus 13.0%), who did not receive any antenatal care (35.9% versus 13.3% and 8.97% for 1–4 or 4+ visits, respectively) were significantly more likely to be zero-dose. Risk of zero-dose status was strongly associated with place of delivery. Compared to children born in a health facility, children born at home or in other locations were significantly more likely to be unvaccinated (24.6% and 28% versus 7.76% and 6.34% for those born in public and private hospitals, respectively). Compared to those with regular exposure to media, mothers with no TV/radio were significantly more likely to have zero-dose children (20.2% versus 12.7%).

3.1.2. Contextual Factors

A majority of children resided in rural locations (75.0%) and in countries with low GDP per capita (54.7%), low government health expenditure (54.7%), low adult female literacy rate (61.3%), low female unemployment rate (70.8%), and high fertility rate (59.8%). Most resided in countries with a moderate or high overall GPI scores (39.6% moderate and 44.5% high). Nearly one-half of children belonged to households in the lowest two wealth index quintiles (26.3% poorest category and 23.1% poorer category). Over one-half of mothers were Christian (55.4%). Nearly one-third of mothers were Muslim (31.6%). Compared to those residing in urban areas, children in rural areas were much more likely to be zero-dose (19.1% versus 8.67%). Risk of zero-dose status diminished with household wealth. Roughly one-fifth of children in the lowest two wealth index quintiles were unvaccinated (23.5% and 20.3% of children in the poorest and poorer households, respectively). By comparison, 14.8% of children in the middle quintile, 10.4% of children in the richer quintile, and 6.59% of children in the richest quintile were zero-dose. Muslim children were significantly more likely to be zero-dose than Christian children (25.2% versus 12.3%). Compared to children residing in less wealthy countries, children residing in countries with high GDP per capita were more likely to be unvaccinated (20.4% versus 15.2% and 15.3% for countries with low and moderate GDP per capita, respectively). Children residing in countries with a low adult female literacy rate (21.9% versus 7.94%) and in the Western Africa and Eastern Africa subregions (18.2% and 20% versus 11.4% and 8.6% for the Middle Africa and Southern Africa subregions, respectively) were significantly more likely to be zero-dose.

3.2. Measures of Association (Fixed Effects)

To summarize, in Model 1 (individual factors), child’s age, birth order, birth weight, mother’s education, mother’s occupation, number of antenatal care visits, place of delivery, and exposure to media, were statistically significant predictors of zero-dose status. In Model 2 (contextual factors measured at the household level), rural residence, wealth index quintile, and religion were statistically significant predictors of zero-dose status. In Model 3 (contextual factors measured at the national level), GDP per capita, female unemployment rate, fertility rate and Global Peace Index were the only factors found to be statistically significant. In Model 4 (full model), nearly all individual factors (excluding place of delivery and exposure to mass media) remained statistically significant. Just two contextual factors, household wealth index quintile and national GDP per capita remained statistically significant. Results from Model 4, our preferred specification, are summarized in Figure 1 (individual factors) and Figure 2 (contextual factors) and discussed in greater detail below.

Figure 1.

Figure 1

Multi-level analysis of individual factors associated with zero-dose vaccination status among children aged 12–59 months in SSA. Estimates from Model 4 (Table S1). X-axis presented on natural log scale.

Figure 2.

Figure 2

Multi-level analysis of contextual factors associated with zero-dose vaccination status among children aged 12–59 months in SSA. Estimates from Model 4 (Table S1). X-axis presented on natural log scale.

3.2.1. Individual Factors

Children between the ages of 25–36 months were less likely to be zero-dose (aOR: 0.86, 95% CI: 0.76–0.96) compared to children between 12–24 months of age. Compared to first born children, later (fourth or fifth) born children were less likely to be zero-dose (aOR: 0.86, 95% CI: 0.76–0.96). Children with normal birth weight were less likely to be zero-dose (aOR: 0.54, 95% CI: 0.41–0.70) compared to children who were not weighed at birth. The odds of having zero-dose children reduces as mother’s educational attainment increases, such that mothers who completed high school were 49% less likely to have zero-dose children compared to mothers with no education (aOR: 0.51, 95% CI: 0.36–0.71). Similarly, mothers who are employed were 21% less likely to have zero-dose children (aOR: 0.79, 95% CI: 0.71–0.88) compared to mothers who were unemployed. Mothers who received antenatal care were less likely to have zero-dose children, compared to mothers with no antenatal visit, less than four antenatal visits (aOR:0.47, 95% CI 0.32–0.67) and four or more antenatal visits (aOR: 0.36, 95% CI: 0.29–0.45).

3.2.2. Contextual Factors

Compared to children from the poorest households, children from rich households, children from households in the richer (aOR: 0.68, 95% CI: 0.49–0.93), and richest (aOR: 0.67, 95% CI: 0.56–0.80) wealth index quintiles were less likely to be zero-dose. Countries with high GDP per capita were four times more likely to have zero-dose children compared to countries with low GDP per capita (aOR: 3.99, 95% CI: 1.27–12.48).

3.3. Measures of Variation (Random Effects)

As shown in the null model (Model 0, Table S1), there was a significant variation in zero-dose children across the 33 countries (σ2 = 0.79, 95% CI = 0.52–1.20). The ICC coefficient showed low to moderate correlation of zero-dose children within countries (ICC: 19% CI: 14–27%) [47]. The MOR of 2.33 in the null model implied that significant heterogeneity exists across countries. This means that if a child is born in a country with high proportion of zero-dose children, the median risk of being zero-dose would be 2.33 times greater odds. In the full model (Model 4, Table S1), inclusion of the control variable, individual, and contextual factors further reduced the variability within countries (ICC: 5% CI: 4–13%).

Additionally, the full model showed that unexplained heterogeneity in zero-dose children among the countries decreased from MOR of 2.33 to 1.62. However, there is residual variability of likelihood of being zero-dose at the country level. This implies that if a child is born in a country with high proportion of zero-dose children, the median risk of not being vaccinated would have 1.62 greater odds. Variations in zero-dose children across countries were mostly explained by country-level variables (PCV = 68.35%), followed by individual-level variables (PCV = 34.18%), and household-level variables (PCV = 15.19%).

4. Discussion

This multi-country study estimated the prevalence of zero-dose vaccination status and examined the individual and contextual factors associated with zero-dose vaccination status among children aged 12–59 months. Child’s age, birth order, birth weight, mother’s education, mother’s occupation, and number of antenatal care visits were found to be associated with zero-dose vaccination status. Additionally, children from rich households were less likely to be zero-dose than their counterparts from poor households. Countries with high GDP per capita were four times more likely to have zero-dose children compared to countries with low GDP per capita.

The study findings support our hypothesis of high prevalence of zero-dose children in SSA, with approximately 17% children identified with zero-dose status. To the best of our knowledge, this is the first study to estimate the prevalence of children with zero-dose vaccination status, using nationally representative surveys of 33 countries in SSA. Our study mirrors the result of Bosch-Capblanch et al., who reported prevalence of 9.9% of zero-dose children aged 12–59 months in LMICs [25]. Therefore, the current study underscores the need to increase efforts to move the zero-dose status children to fully vaccinated status in SSA.

Between 1980 and 2010, there was a significant decrease in the number of unimmunized children in SSA, most of which were achieved through the GAVI initiative [48,49,50,51]. In 2019, the Global Burden of Disease (GBD) reported that the majority of zero-dose children are in LMICs [27]. With the IA2030 agenda to vaccinate all children, the Vaccine Alliance launched a global movement to reach these communities and help give zero-dose children a healthy and successful future [51]. To sustain the progress made on early child vaccination, a massive vaccination for all children will be required across the globe, particularly in SSA, where zero-dose children exist the most [26].

Early childhood immunization in SSA is considerably low [52]. Studies have reported that approximately 17 million children in LMIC are yet to receive a single dose vaccines [18,26,28]. The majority of these unvaccinated children live in the inner communities of SSA countries that are difficult to access by healthcare workers [53]. In 2020, as a result of the COVID-19 pandemic, most LMICs faced several challenges in basic healthcare services without exceptions to childhood immunization [25]. Therefore, the number of zero-dose children is expected to double as a result of the COVID-19 pandemic [54]. Apart from COVID-19 pandemic, insurgency, conflicts, and war affects childhood immunization [55,56]. Consequently, these communities are likely to suffer from impending factors such as extreme poverty, gender inequality and lack of social amenities as indicators to influence childhood vaccination coverage. Surprisingly, our study did not find an association between conflict, safety, and peace index of a country to be associated with zero-dose children.

Other factors that influence zero-dose vaccination include but are not limited to inequality among countries, population size, lack of vaccination services, attitude of healthcare workers toward mothers, maternal education, vaccine hesitancy and political instability [27,31,52,54,57]. Socioeconomic factors as well as perception of the risk of vaccination also pose a huge threat to early childhood vaccination [26,58,59].

The current study further confirms our second hypothesis that both individual and contextual factors play a role in zero-dose children in SSA. For example, mothers who received antenatal care were less likely to have zero-dose children, compared to mothers with no antenatal visit. This holds true in previous studies [60,61,62]. Prior studies have shown that mother’s age and mother’s level of education can influence early child vaccination [52,63,64]. On the other hand, mothers with no education as well as those who are unemployed are less likely to vaccinate their children [65,66,67]. The present study confirmed that mothers with higher educational achievement are less likely to have zero-dose children compared to mothers with no education.

Previous studies have reported that birthweight is an important predictor of childhood vaccination in SSA. O’Leary et al. found that LBW children in Ghana were less likely to receive BCG immunization [68,69]. Their study further indicates that regardless of birthplace, vaccination declines with decreasing birth weight [68]. Similarly, research of Roth et al. conducted in Guinea-Bissau, found that children with LBW were twice as likely to be unvaccinated than those with normal birth weight [70]. The present study confirms that children with normal birthweight were less likely to have zero-dose vaccination status compared to children who were not weighed at birth. Nevertheless, fourth to fifth born children were less likely to have zero-dose vaccination status compared to first born children. This has been reported in a similar study [23].

For more than two decades, scientists, epidemiologists and other stakeholders in the healthcare sector have observed that imbalance in wealth index remains a challenge in delivering healthcare services in SSA [63,71]. Consequently, this study confirms that most households fall within the poorest and poorer categories of wealth index. Households in the middle, richer and richest wealth quintiles are predominantly located in urban areas and likely to have access to good health care facilities. Notably, the wealth index may have a social influence; children from richer households appear to have higher odds of receiving early vaccination than children from poor households, who mainly dominate the zero-dose group. Surprisingly, this study confirms that certain countries with high GDP per capita are four times more likely to have zero-dose children compared to countries with low GDP per capita. This could pertain to the relative wealth index within each country [72]. As such, countries with large revenues from natural resources could appear better off than others even when few people earn sizeable incomes [72]. For instance, Nigeria, with a high GDP per capita, has the highest number of zero-dose children [28]. The number of zero-dose children in countries with high GDP per capita could be attributed to population size, government regulation and unfair health policies.

In light of recent goals set by the Immunization Agenda 2030 (IA2030), including reducing the number of zero-dose children by half, research that goes beyond coverage to identify populations and groups of children at greater risk of being unvaccinated is urgently needed. While much work remains, our results can begin to inform efforts to identify and reach children who have not received any vaccines. Our data suggest that mother’s education, employment, and receipt of antenatal healthcare services may serve as useful indicators in screening tools developed to proactively identify children at risk of being unvaccinated. Screening tools might also incorporate an abbreviated asset index, such as the EquityTool [73], as lower household wealth is strongly associated with zero-dose vaccination status. Our findings also suggest that the number of zero-dose children may be reduced by increasing access to antenatal healthcare services or by educating girls and women. More work is needed to evaluate the effects of specific interventions, including targeted healthcare campaigns and awareness creation. Additional work employing geospatial analysis and modeling strategies could be applied to address issues surrounding zero-dose children and ultimately improve the health and future of children in SSA [25,31,57].

The following limitations of this study are worth noting. First, this study relied on a secondary analysis of publicly available survey data, which might have impacted the findings. Second, survey years and the timing of national measures differ across the countries. To address this, we included birth year as a partial control for common trends over the sample period and to adjust for effects of unobserved temporal factors. Third, given the cross-sectional nature of the data, this study cannot establish causality. However, using nationally representative data from 33 country in SSA, findings from this study is robust and can be used for policy intervention in SSA. It can also help push towards attaining the IA2030 and SDGs agenda. Fourth, to assess the association between zero-dose children and the explanatory variables, the current study utilized multi-level models. Despite the statistical significance of these variables, these models may affect the generalization of the findings presented in our study. Hence, further studies are required to validate the findings presented in the current study.

Acknowledgments

The Demographic and Health Surveys program are appreciated for granting access to use the data for this research.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/vaccines10071052/s1, Table S1: Multi-level analysis of factors associated with zero-dose vaccination status among children aged 12–59 months in SSA.

Author Contributions

Conceptualization C.E.O., N.L.H. and B.O.; Database preparation: C.E.O. and N.L.H.; Methodology: C.E.O., N.L.H., B.O., Z.L. and J.W.H.; First analysis: C.E.O. and N.L.H.; Data interpretation: C.E.O., N.L.H., B.O., Z.L. and J.W.H.; First draft: C.E.O. and N.L.H.; Critical manuscript revision: C.E.O., N.L.H., B.O., Z.L. and J.W.H. All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

The organizations who administered the surveys were responsible for ethical clearance according to the norms of each country.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the surveys.

Data Availability Statement

All the analyses were carried out using publicly available datasets that can be obtained directly from the DHS (https://dhsprogram.com/) (accessed 16 April 2022), World Bank (https://www.worldbank.org/) (accessed 16 April 2022), and Vision of Humanity (https://www.visionofhumanity.org/maps/#/) (accessed 16 April 2022) websites.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Funding Statement

This work was partially supported by a SPARC Graduate Research Grant from the Office of the Vice President for Research at the University of South Carolina.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Maman K., Zöllner Y., Greco D., Duru G., Sendyona S., Remy V. The value of childhood combination vaccines: From beliefs to evidence. Hum. Vaccines Immunother. 2015;11:2132–2141. doi: 10.1080/21645515.2015.1044180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kc A., Nelin V., Raaijmakers H., Kim H.J., Singh C., Målqvist M. Increased immunization coverage addresses the equity gap in Nepal. Bull. World Health Organ. 2017;95:261–269. doi: 10.2471/BLT.16.178327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.WHO Global Routine Immunization Strategies and Practices (GRISP): A Companion Document to the Global Vaccine Action Plan. 2016. [(accessed on 15 March 2021)]. (GVAP) Available online: http://apps.who.int/iris/bitstream/10665/204500/1/9789241510103_eng.pdf.
  • 4.Kretsinger K., Gasasira A., Poy A., Porter K.A., Everts J., Salla M., Brown K.H., Wassilak S.G.F., Nshimirimana D. Polio Eradication in the World Health Organization African Region, 2008–2012. J. Infect. Dis. 2014;210((Suppl. 1)):23–29. doi: 10.1093/infdis/jiu408. [DOI] [PubMed] [Google Scholar]
  • 5.Waziri N.E., Ohuabunwo C.J., Nguku P.M., Ogbuanu I.U., Gidado S., Biya O., Wiesen E.S., Vertefeuille J., Townes D., Oyemakinde A., et al. Polio eradication in Nigeria and the role of the national stop transmission of polio program, 2012–2013. J. Infect. Dis. 2014;210((Suppl. 1)):S111–S117. doi: 10.1093/infdis/jiu199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.WHO The Measles & Rubella Initiative Welcomes World Health Assembly Commitment to Measles and Rubella Elimination Goals. [(accessed on 15 March 2020)]. Available online: https://www.who.int/immunization/newsroom/measles_rubella_wha_elimination_goals_statement_may12/en/
  • 7.Brownwright T.K., Dodson Z.M., Van Panhuis W.G. Spatial clustering of measles vaccination coverage among children in sub-Saharan Africa. BMC Public Health. 2017;17:1–7. doi: 10.1186/s12889-017-4961-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Wobudeya E., Lukoye D., Lubega I.R., Mugabe F., Sekadde M., Musoke P. Epidemiology of tuberculosis in children in Kampala district, Uganda, 2009–2010; a retrospective cross-sectional study. BMC Public Health. 2015;15:1–8. doi: 10.1186/s12889-015-2312-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Antai D. Inequitable childhood immunization uptake in Nigeria: A multilevel analysis of individual and contextual determinants. BMC Infect. Dis. 2009;9:181. doi: 10.1186/1471-2334-9-181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wiysonge C.S., Uthman O.A., Ndumbe P.M., Hussey G.D. Individual and contextual factors associated with low childhood immunisation coverage in Sub-Saharan Africa: A multilevel analysis. PLoS ONE. 2012;7:e37905. doi: 10.1371/journal.pone.0037905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.WHO 1 in 5 Children in Africa Do Not Have Access to Life-Saving Vaccines. WHO|Regional Office for Africa. [(accessed on 29 August 2020)]. Available online: https://www.afro.who.int/news/1-5-children-africa-do-not-have-access-life-saving-vaccines.
  • 12.WHO|Regional Office for Africa Immunization. [(accessed on 24 June 2022)]. Available online: https://www.afro.who.int/health-topics/immunization.
  • 13.WHO Reaching Every District (RED) Approach: A Way to Improve Immunization Performance. [(accessed on 19 November 2021)]. Available online: https://www.who.int/bulletin/volumes/86/3/07-042127/en/
  • 14.WHO Global Immunization Vision and Strategy 2006–2015. [(accessed on 17 October 2019)]. Available online: https://apps.who.int/iris/bitstream/handle/10665/69146/WHO_IVB_05.05.pdf;jsessionid=8C20744530CE6D2D34CAD14342C0166C?sequence=1.
  • 15.WHO Global Vaccine Action Plan 2011–2020. WHO. [(accessed on 19 March 2021)]. Available online: http://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011_2020/en/
  • 16.Ikilezi G.E., Micah A., Bachmeier S.D.E., Cogswell I., Maddison E.R., Stutzman H.N., Tsakalos G., Brenzel L., Dieleman J.L. Estimating total spending by source of funding on routine and supplementary immunisation activities in low-income and middle-income countries, 2000–2017: A financial modelling study. Lancet. 2021;398:1875–1893. doi: 10.1016/S0140-6736(21)01591-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.UNICEF Immunization Data UNICEF DATA. [(accessed on 29 September 2021)]. Available online: https://data.unicef.org/topic/child-health/immunization/
  • 18.UNICEF Vaccination and Immunization Statistics. UNICEF DATA. [(accessed on 4 February 2022)]. Available online: https://data.unicef.org/topic/child-health/immunization/
  • 19.WHO-UNICEF Coverage Estimates WHO World Health Organization: Immunization, Vaccines and Biologicals. [(accessed on 1 October 2020)]. Vaccine Preventable Diseases Vaccines Monitoring System 2018 Global Summary Reference Time Series: DTP3. Available online: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragedtp3.html.
  • 20.WHO Childhood Vaccination in Africa and Asia: The Effects of Parents’ Knowledge and Attitudes. [(accessed on 20 January 2021)]. Available online: https://www.who.int/bulletin/volumes/86/6/07-047159/en/
  • 21.WHO Implementing the Immunization Agenda 2030: A Framework for Action through Coordinated Planning, Monitoring & Evaluation, Ownership & Accountability, and Communications & Advocacy. 2020. [(accessed on 4 February 2022)]. Available online: https://cdn.who.int/media/docs/default-source/immunization/strategy/ia2030/ia2030_frameworkforactionv04.pdf?sfvrsn=e5374082_1&download=true. [DOI] [PMC free article] [PubMed]
  • 22.UNDP Sustainable Development Goals|United Nations Development Programme. [(accessed on 5 February 2022)]. Available online: https://www.undp.org/sustainable-development-goals.
  • 23.Chido-Amajuoyi O.G., Wonodi C., Mantey D., Perez A., McAlister A. Prevalence and correlates of never vaccinated Nigerian children, aged 1–5 years. Vaccine. 2018;36:6953–6960. doi: 10.1016/j.vaccine.2018.10.006. [DOI] [PubMed] [Google Scholar]
  • 24.Cata-Preta B.O., Santos T.M., Mengistu T., Hogan D.R., Barros A.J., Victora C.G. Zero-dose children and the immunisation cascade: Understanding immunisation pathways in low and middle-income countries. Vaccine. 2021;39:4564–4570. doi: 10.1016/j.vaccine.2021.02.072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Arambepola R., Yang Y., Hutchinson K., Mwansa F.D., Doherty J.A., Bwalya F., Ndubani P., Musukwa G., Moss W.J., Wesolowski A., et al. Using geospatial models to map zero-dose children: Factors associated with zero-dose vaccination status before and after a mass measles and rubella vaccination campaign in Southern province, Zambia. BMJ Glob. Health. 2021;6:e007479. doi: 10.1136/bmjgh-2021-007479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Galles N.C., Liu P.Y., Updike R.L., Fullman N., Nguyen J., Rolfe S., Sbarra A.N., Schipp M.F., Marks A., Abady G.G., et al. Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: A systematic analysis for the Global Burden of Disease Study 2020, Release 1. Lancet. 2021;398:503–521. doi: 10.1016/S0140-6736(21)00984-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Murhekar M.V., Kumar M.S. Reaching zero-dose children in India: Progress and challenges ahead. Lancet Glob. Health. 2021;9:e1630–e1631. doi: 10.1016/S2214-109X(21)00406-X. [DOI] [PubMed] [Google Scholar]
  • 28.Johri M., Rajpal S., Subramanian S.V. Progress in reaching unvaccinated (zero-dose) children in India, 1992–2016: A multilevel, geospatial analysis of repeated cross-sectional surveys. Lancet Glob. Health. 2021;9:e1697–e1706. doi: 10.1016/S2214-109X(21)00349-1. [DOI] [PubMed] [Google Scholar]
  • 29.Vanderende K., Gacic-Dobo M., Diallo M., Conklin L.M., Wallace A.S. Global routine vaccination coverage—2017. Morb. Mortal. Wkly. Rep. 2018;67:1261–1264. doi: 10.15585/mmwr.mm6745a2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Bosch-Capblanch X., Banerjee K., Burton A. Unvaccinated children in years of increasing coverage: How many and who are they? Evidence from 96 low- and middle-income countries. Trop. Med. Int. Health. 2012;17:697–710. doi: 10.1111/j.1365-3156.2012.02989.x. [DOI] [PubMed] [Google Scholar]
  • 31.Bobo F.T., Asante A., Woldie M., Dawson A., Hayen A. Child vaccination in sub-Saharan Africa: Increasing coverage addresses inequalities. Vaccine. 2022;40:141–150. doi: 10.1016/j.vaccine.2021.11.005. [DOI] [PubMed] [Google Scholar]
  • 32.The DHS Program—Quality Information to Plan, Monitor and Improve Population, Health, and Nutrition Programs. [(accessed on 16 April 2022)]. Available online: https://dhsprogram.com/
  • 33.The DHS Program—Demographic and Health Survey (DHS) [(accessed on 27 September 2020)]. Available online: https://dhsprogram.com/What-We-Do/Survey-Types/DHS.cfm.
  • 34.The DHS Program—Team and Partners. [(accessed on 27 September 2020)]. Available online: https://dhsprogram.com/Who-We-Are/About-Us.cfm.
  • 35.Croft T.N., Marshall A.M.J., Allen C.K. Guide to DHS Statistics. ICF; Rockville, MD, USA: 2018. [(accessed on 27 September 2020)]. Available online: https://dhsprogram.com/Data/Guide-to-DHS-Statistics/index.cfm. [Google Scholar]
  • 36.Corsi D.J., Neuman M., Finlay J.E., Subramanian S.V. Demographic and health surveys: A profile. Int. J. Epidemiol. 2012;41:1602–1613. doi: 10.1093/ije/dys184. [DOI] [PubMed] [Google Scholar]
  • 37.World Bank Group—International Development, Poverty, & Sustainability. World Bank; Washington, DC, USA: [(accessed on 16 April 2022)]. Available online: https://www.worldbank.org/en/home. [Google Scholar]
  • 38.Global Peace Index Map » The Most & Least Peaceful Countries. Vision of Humanity. [(accessed on 16 April 2022)]. Available online: https://www.visionofhumanity.org/maps/
  • 39.Ren R. Note on de-Normalization of DHS Standard Weight. The DHS Program User Forum: Weighting data, Question Re-Weighting Combined Survey Data. [(accessed on 28 November 2021)]. Available online: https://userforum.dhsprogram.com/index.php?t=msg&goto=81&S=Google.
  • 40.United Nations Department of Economic and Social Affairs Population Dynamics: World Population Prospects. [(accessed on 28 November 2021)]. Available online: https://population-un-org.pallas2.tcl.sc.edu/wpp/Download/Standard/Population/
  • 41.Midi H., Sarkar S., Rana S. Collinearity diagnostics of binary logistic regression model. J. Interdiscip. Math. 2010;13:253–267. doi: 10.1080/09720502.2010.10700699. [DOI] [Google Scholar]
  • 42.Merlo J., Chaix B., Yang M., Lynch J., Råstam L. A brief conceptual tutorial of multilevel analysis in social epidemiology: Linking the statistical concept of clustering to the idea of contextual phenomenon. J. Epidemiol. Commun. Health. 2005;59:443–449. doi: 10.1136/jech.2004.023473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Merlo J., Yang M., Chaix B., Lynch J., Råstam L. A brief conceptual tutorial on multilevel analysis in social epidemiology: Investigating contextual phenomena in different groups of people. J. Epidemiol. Commun. Health. 2005;59:729–736. doi: 10.1136/jech.2004.023929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Merlo J., Chaix B., Ohlsson H., Beckman A., Johnell K., Hjerpe P., Råstam L., Larsen K. A brief conceptual tutorial of multilevel analysis in social epidemiology: Using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J. Epidemiol. Commun. Health. 2006;60:290–297. doi: 10.1136/jech.2004.029454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Larsen K. Appropriate Assessment of Neighborhood Effects on Individual Health: Integrating Random and Fixed Effects in Multilevel Logistic Regression. Am. J. Epidemiol. 2005;161:81–88. doi: 10.1093/aje/kwi017. [DOI] [PubMed] [Google Scholar]
  • 46.Austin P.C., Merlo J. Intermediate and advanced topics in multilevel logistic regression analysis. Stat. Med. 2017;36:3257–3277. doi: 10.1002/sim.7336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.De Vaus D. Analyzing Social Science Data: 50 Key Problems in Data Analysis. SAGE; Los Angeles, CA, USA: 2002. [Google Scholar]
  • 48.Chard A.N., Gacic-Dobo M., Diallo M.S., Sodha S.V., Wallace A.S. Routine Vaccination Coverage—Worldwide, 2019. Morb. Mortal. Wkly. Rep. 2020;69:1706–1710. doi: 10.15585/mmwr.mm6945a7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Burch A. Progress and Challenges with Achieving Universal Immunization Coverage. 2020. [(accessed on 5 February 2022)]. p. 22. Available online: https://www.who.int/publications/m/item/progress-and-challenges-with-achievinguniversal-immunization-coverage.
  • 50.Malhame M., Baker E., Gandhi G., Jones A., Kalpaxis P., Iqbal R., Momeni Y., Nguyen A. Shaping markets to benefit global health—A 15-year history and lessons learned from the pentavalent vaccine market. Vaccine: X. 2019;2:100033. doi: 10.1016/j.jvacx.2019.100033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Gavi Zero-Dose Children and Missed Communities. [(accessed on 5 February 2022)]. Available online: https://www.gavi.org/our-alliance/strategy/phase-5-2021-2025/equity-goal/zero-dose-children-missed-communities.
  • 52.Tesema G.A., Tessema Z.T., Tamirat K.S., Teshale A.B. Complete basic childhood vaccination and associated factors among children aged 12–23 months in East Africa: A multilevel analysis of recent demographic and health surveys. BMC Public Health. 2020;20:1–14. doi: 10.1186/s12889-020-09965-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Janusz C.B., Frye M., Mutua M.K., Wagner A.L., Banerjee M., Boulton M.L. Vaccine delay and its association with undervaccination in children in Sub-Saharan Africa. Am. J. Prev. Med. 2020;60:S53–S64. doi: 10.1016/j.amepre.2020.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Causey K., Fullman N., Sorensen R.J.D., Galles N.C., Zheng P., Aravkin A., Danovaro-Holliday M.C., Martinez-Piedra R., Sodha S.V., Velandia-González M.P., et al. Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: A modelling study. Lancet. 2021;398:522–534. doi: 10.1016/S0140-6736(21)01337-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Grundy J., Biggs B.-A. The Impact of conflict on immunisation coverage in 16 countries. Int. J. Health Policy Manag. 2018;8:211–221. doi: 10.15171/ijhpm.2018.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Sato R. Effect of armed conflict on vaccination: Evidence from the Boko haram insurgency in northeastern Nigeria. Confl. Health. 2019;13:1–10. doi: 10.1186/s13031-019-0235-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Stoop N., Hirvonen K., Maystadt J.-F. Institutional mistrust and child vaccination coverage in Africa. BMJ Glob. Health. 2021;6:e004595. doi: 10.1136/bmjgh-2020-004595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Jani J.V., De Schacht C., Jani I.V., Bjune G. Risk factors for incomplete vaccination and missed opportunity for immunization in rural Mozambique. BMC Public Health. 2008;8:161–167. doi: 10.1186/1471-2458-8-161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Abdulraheem I.S., Onajole A.T., Jimoh A.A.G., Oladipo A.R. Reasons for incomplete vaccination and factors for missed opportunities among rural Nigerian children. J. Public Health Epidemiol. 2011;3:194–203. doi: 10.5897/JPHE.9000106. [DOI] [Google Scholar]
  • 60.Laryea D.O., Parbie E.A., Frimpong E. Timeliness of childhood vaccine uptake among children attending a tertiary health service facility-based immunisation clinic in Ghana. BMC Public Health. 2014;14:90. doi: 10.1186/1471-2458-14-90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Sarker A.R., Akram R., Ali N., Chowdhury Z.I., Sultana M. Coverage and determinants of full immunization: Vaccination coverage among Senegalese children. Medicina. 2019;55:480. doi: 10.3390/medicina55080480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Noh J.-W., Kim Y.M., Akram N., Yoo K.-B., Park J., Cheon J., Kwon Y.D., Stekelenburg J. Factors affecting complete and timely childhood immunization coverage in Sindh, Pakistan; A secondary analysis of cross-sectional survey data. PLoS ONE. 2018;13:e0206766. doi: 10.1371/journal.pone.0206766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Oleribe O., Kumar V., Awosika-Olumo A., Taylor S.D. Individual and socioeconomic factors associated with childhood immunization coverage in Nigeria. Pan Afr. Med. J. 2017;26:220. doi: 10.11604/pamj.2017.26.220.11453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Feyisetan B.J., Asa S., Ebigbola J.A. Mothers’ management of childhood diseases in Yorubaland: The influence of cultural beliefs. Health Transit. Rev. Cult. Social. Behav. Determ. Health. 1997;7:221–234. [PubMed] [Google Scholar]
  • 65.Streatfield K., Singarimbun M., Diamond I. Maternal education and child immunization. Demography. 1990;27:447–455. doi: 10.2307/2061378. [DOI] [PubMed] [Google Scholar]
  • 66.Burroway R., Hargrove A. Education is the antidote: Individual- and community-level effects of maternal education on child immunizations in Nigeria. Soc. Sci. Med. 2018;213:63–71. doi: 10.1016/j.socscimed.2018.07.036. [DOI] [PubMed] [Google Scholar]
  • 67.Özer M., Fidrmuc J., Eryurt M.A. Maternal education and childhood immunization in Turkey. Health Econ. 2018;27:1218–1229. doi: 10.1002/hec.3770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.O’Leary M., Thomas S., Hurt L., Floyd S., Shannon C., Newton S., Thomas G., Amenga-Etego S., Tawiah-Agyemang C., Gram L., et al. Vaccination timing of low-birth-weight infants in rural Ghana: A population-based, prospective cohort study. Bull. World Health Organ. 2016;94:442–451. doi: 10.2471/BLT.15.159699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.O’Leary M., Edmond K., Floyd S., Hurt L., Shannon C., Thomas G., Newton S., Kirkwood B., Thomas S. Neonatal vaccination of low birthweight infants in Ghana. Arch. Dis. Child. 2017;102:145–151. doi: 10.1136/archdischild-2016-311227. [DOI] [PubMed] [Google Scholar]
  • 70.Roth A., Jensen H., Garly M.-L., Djana Q., Martins C.L., Sodemann M., Rodrigues A., Aaby P. Low birth weight infants and calmette-guérin bacillus vaccination at birth. Pediatr. Infect. Dis. J. 2004;23:544–550. doi: 10.1097/01.inf.0000129693.81082.a0. [DOI] [PubMed] [Google Scholar]
  • 71.Geweniger A., Abbas K.M. Childhood vaccination coverage and equity impact in Ethiopia by socioeconomic, geographic, maternal, and child characteristics. Vaccine. 2020;38:3627–3638. doi: 10.1016/j.vaccine.2020.03.040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Rutstein S.O., Staveteig S. Making the Demographic and Health Surveys Wealth Index Comparable. ICF International; Rockville, MD, USA: 2014. [Google Scholar]
  • 73.Home Equity Tool. [(accessed on 24 June 2022)]. Available online: https://www.equitytool.org/

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

All the analyses were carried out using publicly available datasets that can be obtained directly from the DHS (https://dhsprogram.com/) (accessed 16 April 2022), World Bank (https://www.worldbank.org/) (accessed 16 April 2022), and Vision of Humanity (https://www.visionofhumanity.org/maps/#/) (accessed 16 April 2022) websites.


Articles from Vaccines are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES